李邇王工業(yè)技術(shù)(上海)有限公司,創(chuàng)立于2021年5月11日。公司初創(chuàng)人員均為深耕制藥裝備市場多年的從業(yè)人員,當年的這些外資企業(yè)的技術(shù)銷售管理人員,受“實業(yè)報國”的理念感召而聚集在一起。

從初期的為制藥企業(yè)注射劑生產(chǎn)線提供易耗品和為生產(chǎn)線提供預防性維護服務,逐步發(fā)展到對老舊生產(chǎn)線改造,直至將公司的產(chǎn)品市場定位于為制藥企業(yè)生產(chǎn)定制化制藥裝備,新興的公司慢慢發(fā)展壯大。

公司將“持續(xù)創(chuàng)新,不斷探尋制藥裝備的最優(yōu)解決方案”作為使命,踐行諾言,不斷提升科創(chuàng)實力,引導創(chuàng)造新型設備,助力醫(yī)藥企業(yè)為病患提供可靠的藥品。公司奉行CIIC的企業(yè)價值觀:“用戶需求”(Customer),“創(chuàng)新”(Innovation),“正直誠信”(Integration),“合作共贏”(Cooperation),秉行著這種企業(yè)文化,把產(chǎn)品質(zhì)量和用戶要求作為企業(yè)立命之本。并以此價值觀引導員工展開行動,去實現(xiàn)共同的使命和愿景。

我們堅信隨著醫(yī)療衛(wèi)生水平不斷提升和藥品需求不斷加大,生物制藥產(chǎn)業(yè)將持續(xù)穩(wěn)定發(fā)展,持續(xù)創(chuàng)新的公司必將隨著產(chǎn)業(yè)的發(fā)展而成長壯大。

Lee&Wang Industrial Technology (Shanghai) Co., Ltd was founded on May 11, 2021. The startup person are all professionals who have been deeply involved in the pharmaceutical equipment market for many years. These foreign-funded enterprises technicians, sales and management employees were inspired and gathered by national concept ‘industry serving the country’.

From providing spare parts and preventive maintenance services for injection production filling lines in the early stages, gradually developed to retrofitting old production lines, until positioning the company's products to produce customized pharmaceutical equipment for pharmaceutical companies, emerging companies gradually grow up.

The company regards ‘continuous innovation and exploration of the best solutions for pharmaceutical equipment’ as its mission, fulfills its promise, continuously enhances its scientific and technological innovation capabilities, guides the creation of new equipment, and assists pharmaceutical enterprises in providing reliable drugs for patients. The company adheres to the company values of CIIC: Customer Requirement, Innovation, Integrity, and Cooperation of Win-win. Adhering to this value, the company puts product quality and user requirements as the foundation of its mission. Lead employees to take action to realize the common mission and vision.

We firmly believe that with the continuous improvement of medical and health standards and the increasing demand for drugs, the biopharmaceutical industry will continue to develop steadily, and companies with continuous innovation will grow and grow with the development of the industry.